IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Washington University School of Medicine
National Taiwan University Hospital
Sir Run Run Shaw Hospital
McGill University Health Centre/Research Institute of the McGill University Health Centre
University of Texas Southwestern Medical Center
Oslo University Hospital
Institut Paoli-Calmettes
City of Hope Medical Center
University of Pittsburgh
University of Utah
The First People's Hospital of Changzhou
St. Joseph's Hospital, Florida